Search Results - "Avery, D."

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability by Guedan, Sonia, Madar, Aviv, Casado-Medrano, Victoria, Shaw, Carolyn, Wing, Anna, Liu, Fang, Young, Regina M, June, Carl H, Posey, Jr, Avery D

“…Chimeric antigen receptor-T (CAR-T) cell therapies can eliminate relapsed and refractory tumors, but the durability of antitumor activity requires in vivo…”
Get full text

Forks in the road for CAR T and CAR NK cell cancer therapies by Dagher, Oula K., Posey, Avery D.

“…The advent of chimeric antigen receptor (CAR) T cell therapy has resulted in unprecedented long-term clearance of relapse/refractory hematological malignancies…”
Get full text

Advances in cancer immunotherapies by Dagher, Oula K., Schwab, Robert D., Brookens, Shawna K., Posey, Avery D.

“…Therapeutic modalities that engage the immune system to recognize and eliminate cancer, known as cancer immunotherapy, has emerged as a distinct pillar of…”
Get full text

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology by Watanabe, Keisuke, Kuramitsu, Shunichiro, Posey, Jr, Avery D, June, Carl H

“…A major obstacle for chimeric antigen receptor (CAR) T cell therapy in solid tumors is the lack of truly tumor-specific target antigens, which translates to…”
Get full text

Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunity by Sosnoski, Heather M, Posey, Jr, Avery D

“…Anti-CD19 CAR T cells were among the last decade's scientific breakthroughs, achieving remarkable remissions in patients with B cell leukemias and lymphomas…”
Get more information

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma by Posey, Avery D., Schwab, Robert D., Boesteanu, Alina C., Steentoft, Catharina, Mandel, Ulla, Engels, Boris, Stone, Jennifer D., Madsen, Thomas D., Schreiber, Karin, Haines, Kathleen M., Cogdill, Alexandria P., Chen, Taylor J., Song, Decheng, Scholler, John, Kranz, David M., Feldman, Michael D., Young, Regina, Keith, Brian, Schreiber, Hans, Clausen, Henrik, Johnson, Laura A., June, Carl H.

“…Genetically modified T cells expressing chimeric antigen receptors (CARs) demonstrate robust responses against lineage restricted, non-essential targets in…”
Get full text

Reprogramming T cells to target glycans and overcome glycan‐mediated immunosuppression for cancer therapy by Posey, Avery D.

“…T‐lymphocytes (or T‐cells) exhibit rapid proliferation and cytotoxicity after immune recognition of foreign or non‐self antigens. Cancerous cells can often…”
Get full text

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells by Guedan, Sonia, Chen, Xi, Madar, Aviv, Carpenito, Carmine, McGettigan, Shannon E., Frigault, Matthew J., Lee, Jihyun, Posey, Avery D., Scholler, John, Scholler, Nathalie, Bonneau, Richard, June, Carl H.

“…With the notable exception of B-cell malignancies, the efficacy of chimeric antigen receptor (CAR) T cells has been limited, and CAR T cells have not been…”
Get full text

Driving cars to the clinic for solid tumors by Castellarin, Mauro, Watanabe, Keisuke, June, Carl H., Kloss, Christopher C., Posey, Avery D.

“…FDA approval of chimeric antigen receptor T cells (CART cells) is the culmination of several decades of technology development and interrogation of the…”
Get full text

Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies by Parker, Kevin R., Migliorini, Denis, Perkey, Eric, Yost, Kathryn E., Bhaduri, Aparna, Bagga, Puneet, Haris, Mohammad, Wilson, Neil E., Liu, Fang, Gabunia, Khatuna, Scholler, John, Montine, Thomas J., Bhoj, Vijay G., Reddy, Ravinder, Mohan, Suyash, Maillard, Ivan, Kriegstein, Arnold R., June, Carl H., Chang, Howard Y., Posey, Avery D., Satpathy, Ansuman T.

“…CD19-directed immunotherapies are clinically effective for treating B cell malignancies but also cause a high incidence of neurotoxicity. A subset of patients…”
Get full text

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells by Kawalekar, Omkar U., O’Connor, Roddy S., Fraietta, Joseph A., Guo, Lili, McGettigan, Shannon E., Posey, Avery D., Patel, Prachi R., Guedan, Sonia, Scholler, John, Keith, Brian, Snyder, Nathaniel W., Blair, Ian A., Milone, Michael C., June, Carl H.

“…Chimeric antigen receptors (CARs) redirect T cell cytotoxicity against cancer cells, providing a promising approach to cancer immunotherapy. Despite extensive…”
Get full text

The Health Benefits of Muscular Fitness for Children and Adolescents: A Systematic Review and Meta-Analysis by Smith, Jordan J., Eather, Narelle, Morgan, Philip J., Plotnikoff, Ronald C., Faigenbaum, Avery D., Lubans, David R.

“…Background Physical fitness during childhood and adolescence has been identified as an important determinant of current and future health status. While…”
Get full text

Sweet Immune Checkpoint Targets to Enhance T Cell Therapy by Derosiers, Nohelly, Aguilar, William, DeGaramo, David A, Posey, Jr, Avery D

“…Despite tremendous success against hematological malignancies, the performance of chimeric Ag receptor T cells against solid tumors remains poor. In such…”
Get full text

Glycan-directed CAR-T cells by Steentoft, Catharina, Migliorini, Denis, King, Tiffany R, Mandel, Ulla, June, Carl H, Posey, Jr, Avery D

“…Cancer immunotherapy is rapidly advancing in the treatment of a variety of hematopoietic cancers, including pediatric acute lymphoblastic leukemia and diffuse…”
Get full text

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager by Wing, Anna, Fajardo, Carlos Alberto, Posey, Jr, Avery D, Shaw, Carolyn, Da, Tong, Young, Regina M, Alemany, Ramon, June, Carl H, Guedan, Sonia

“…T cells expressing chimeric antigen receptors (CART) have shown significant promise in clinical trials to treat hematologic malignancies, but their efficacy in…”
Get more information

CAR T-Cell Therapies in Glioblastoma: A First Look by Migliorini, Denis, Dietrich, Pierre-Yves, Stupp, Roger, Linette, Gerald P, Posey, Jr, Avery D, June, Carl H

“…Glioblastoma is an aggressive malignancy with a poor prognosis. The current standard of care for newly diagnosed glioblastoma patients includes surgery to the…”
Get full text

Resistance Training for Children and Adolescents by Stricker, Paul R, Faigenbaum, Avery D, McCambridge, Teri M

“…Resistance training is becoming more important as an integral part of comprehensive sport training regimens, school physical education classes, and…”
Get full text

Expression of inducible factors reprograms CAR-T cells for enhanced function and safety by Smole, Anže, Benton, Alexander, Poussin, Mathilde A., Eiva, Monika A., Mezzanotte, Claudia, Camisa, Barbara, Greco, Beatrice, Sharma, Prannda, Minutolo, Nicholas G., Gray, Falon, Bear, Adham S., Baroja, Miren L., Cummins, Casey, Xu, Chong, Sanvito, Francesca, Goldgewicht, Andrea Lang, Blanchard, Tatiana, Rodriguez-Garcia, Alba, Klichinsky, Michael, Bonini, Chiara, June, Carl H., Posey, Avery D., Linette, Gerald P., Carreno, Beatriz M., Casucci, Monica, Powell, Daniel J.

“…Despite the success of CAR-T cell cancer immunotherapy, challenges in efficacy and safety remain. Investigators have begun to enhance CAR-T cells with the…”
Get full text

National Strength and Conditioning Association Position Statement on Long-Term Athletic Development by Lloyd, Rhodri S, Cronin, John B, Faigenbaum, Avery D, Haff, G Gregory, Howard, Rick, Kraemer, William J, Micheli, Lyle J, Myer, Gregory D, Oliver, Jon L

“…ABSTRACTLloyd, RS, Cronin, JB, Faigenbaum, AD, Haff, GG, Howard, R, Kraemer, WJ, Micheli, LJ, Myer, GD, and Oliver, JL. National Strength and Conditioning…”
Get full text

Chimeric Antigen Receptor T-Cell Therapy: Current Perspective on T Cell–Intrinsic, T Cell–Extrinsic, and Therapeutic Limitations by Brookens, Shawna K., Posey, Avery D.

“…Genetically engineered chimeric antigen receptor (CAR) T-cell therapy leverages the ability of the immune system to eliminate tumors and redirects cytotoxic…”
Get full text